Intracellular Calcium Increase in Epileptiform Activity: Modulation by Levetiracetam and Lamotrigine
The DOI matches its Crossref record.
Abstract
Summary: Purpose: Alterations in neuronal calcium (Ca 2+) homeostasis are believed to play an essential role in the generation and propagation of epileptiform events. Levetiracetam (LEV) and lamotrigine (LTG), novel antiepileptic drugs (AEDs), were tested on epileptiform events and the corresponding elevations in intracellular Ca 2+ concentration ([Ca 2+]i) recorded from rat neocortical slices. Methods: Electrophysiological recordings were performed from single pyramidal neurons from a slice preparation. Spontaneous epileptiform events consisting of long‐lasting, repetitive paroxysmal depolarization shifts (PDSs) and interictal spike activity were induced by reducing the magnesium concentration from the solution and by adding bicuculline and 4‐aminopyridine. Simultaneously, microfluorimetric measurements of [Ca 2+]i were performed. Optical imaging with Ca 2+ indicators revealed a close correlation between Ca 2+ transients and epileptiform events. Results: Both LEV and LTG were able to reduce both amplitude and duration of PDSs, as well as the concomitant elevation in [Ca 2+]i, in a dose‐dependent fashion. Whole‐cell patch‐clamp recordings from isolated neocortical neurons revealed that LEV significantly reduced N‐, and partially P/Q‐type high‐voltage‐activated (HVA) Ca 2+ currents, whereas sodium currents were unaffected. Interestingly, the inhibitory effects of LEV were mimicked and occluded by LTG or by a combination of ω‐conotoxin GVIA and ω‐agatoxin IVA, selective blockers of N‐ and P/Q‐type HVA channels, respectively, suggesting a common site of action for these AEDs. Conclusions: These results demonstrate that large, transient elevations in neuronal [Ca 2+]i correlate to epileptiform discharges. The antagonistic effects of LEV and LTG on [Ca 2+]i overload might represent the basis for their anticonvulsant efficacy and could preserve neuronal viability.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Molecular Targets for Antiepileptic Drug Development
Meldrum, B. S., & Rogawski, M. A. (2007) · Neurotherapeutics · doi:10.1016/j.nurt.2006.11.010 · Cited by 468
Malykh, A. G., & Sadaie, M. R. (2010) · Drugs · doi:10.2165/11319230-000000000-00000 · Cited by 270
Klitgaard, H., Matagne, A., Nicolas, J., Gillard, M., Lamberty, Y., De Ryck, M., Kaminski, R. M., Leclercq, K., Niespodziany, I., Wolff, C., et al. (2016) · Epilepsia · doi:10.1111/epi.13340 · Cited by 168
Levetiracetam Mechanisms of Action: From Molecules to Systems
Contreras-García, I. J., Cárdenas-Rodríguez, N., Romo-Mancillas, A., Bandala, C., Zamudio, S. R., Gómez-Manzo, S., Hernández-Ochoa, B., Mendoza-Torreblanca, J. G., & Pichardo-Macías, L. A. (2022) · Pharmaceuticals · doi:10.3390/ph15040475 · Cited by 131
“In addition, LEV (100 μM) provoked a partial reduction in P/Q-type HVA Ca2+ currents in the acutely isolated neocortical neurons [137].”
BackgroundA review of the pharmacology and clinical efficacy of brivaracetam
Klein, P., Diaz, A., Gasalla, T., & Whitesides, J. (2018) · Clinical Pharmacology: Advances and Applications · doi:10.2147/cpaa.s114072 · Cited by 99
Metadata
- Authors
- Pisani, A., Bonsi, P., Martella, G., De Persis, C., Costa, C., Pisani, F., Bernardi, G., & Calabresi, P.
- Venue
- Epilepsia
- Publisher
- Wiley
- Published
- 2004-06-28
- Volume
- 45
- Issue
- 7
- Pages
- 719-728
- ISSN
- 0013-9580 (ISSN-L)
- 1528-1167
- OpenAlex
- W1979298238
- Cited by
- 135
- References
- 0
- FWCI
- 4.44
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Intracellular Calcium Increase in Epileptiform Activity: Modulation by Levetiracetam and Lamotrigine. https://app.cochat.ai/papers/10.1111/j.0013-9580.2004.02204.x
- The paper
- Pisani, A., Bonsi, P., Martella, G., De Persis, C., Costa, C., Pisani, F., Bernardi, G., & Calabresi, P. (2004). Intracellular Calcium Increase in Epileptiform Activity: Modulation by Levetiracetam and Lamotrigine. Epilepsia. https://doi.org/10.1111/j.0013-9580.2004.02204.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.